Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure — Stella

Home/Heart Failure With Reduced Ejection Fraction/

View on ClinicalTrials.gov

Recruiting

Back to Heart Failure With Reduced Ejection Fraction trials

Trial locations(1 site)

United States

Johns Hopkins Hospital, Baltimore, Maryland

Key details

Sponsor

Johns Hopkins University

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~50 participants

Started

December 2024

Primary completion

March 2029

Age range

18 Years – 90 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.